Cargando…
The therapeutic potential of modulators of the Hedgehog-Gli signaling pathway
The discovery of small molecules that act as agonists and antagonists of the Hedgehog-Gli signaling pathway, which plays important roles in the embryo and adult, opens a new avenue for the treatment of diseases caused by aberrant suppression or activation of this complex pathway.
Autores principales: | Stecca, Barbara, Altaba, Ariel Ruiz i |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137069/ https://www.ncbi.nlm.nih.gov/pubmed/12437768 |
Ejemplares similares
-
A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers
por: Stecca, Barbara, et al.
Publicado: (2009) -
Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy
por: Pandolfi, Silvia, et al.
Publicado: (2015) -
Non-canonical Hedgehog Signaling Pathway in Cancer: Activation of GLI Transcription Factors Beyond Smoothened
por: Pietrobono, Silvia, et al.
Publicado: (2019) -
Roughing up Smoothened: chemical modulators of Hedgehog signaling
por: King, Randall W
Publicado: (2002) -
Context-dependent signal integration by the GLI code: The oncogenic load, pathways, modifiers and implications for cancer therapy
por: Aberger, Fritz, et al.
Publicado: (2014)